Expert interview on pharmaceutical cannabis
In what way do compulsory testing procedures or quality and safety requirements for pharmaceutical cannabis, hemp-containing foods and cannabinoid-containing cosmetic products differ from each other?
What are the most common reasons for cannabis products failing quality control, or also: is the terpene profile and the quantitative total content of terpenes in flowers and so-called full spectrum extracts from flowers of the same cultivar identical, or comparable, respectively?
Our expert for pharmaceutical cannabis, Dr Maik Siebelmann, answered these and other questions in an expert interview with krautinvest.de, the German-language B2B online magazine for the cannabis industry. The WESSLING expert provided many insights into the range of services offered by our laboratory analyses and revealed why it is purchasing certain services for consultation and expert reports in a targeted manner.
You will find the complete interview here (in German language).
You grow pharmaceutical cannabis or would like to import it?
We are happy to be there for you with our analytics and advice!
- Dr. Maik Siebelmann
- +49 251 13 39 880
- pharma@wessling.de
